BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, July 21, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

High Hopes as AIDS Conference Returns to U.S. at Long Last

July 5, 2012
By Anette Breindl
Later this month, the International AIDS Conference is set to occur on U.S. soil for the first time in more than two decades, and researchers have high hopes for the meeting, whose theme is "Turning the Tide Together."
Read More

Developmental Stalwart Wnt Helps Keep Fat Cells Skinny

July 3, 2012
By Anette Breindl
Wnt is a signaling pathway that plays critical roles in development, and its proteins can go awry in many cancers. Now, researchers from the University of Michigan have gained new insights into the relationship between Wnt signaling, metabolism and mitochondria.
Read More

Gemmus Helping Immune System Pace Itself Against Flu

July 3, 2012
By Anette Breindl
San Francisco-based start-up Gemmus Pharma Inc. closed an angel-backed Series A funding round of $1.45 million last week. The company expects the money and the planned second tranche will take its lead compound, GP1001, to a planned 2014 investigational new drug application (IND).
Read More

Repeat Heart Attack Work Paints Systems-Level Picture of Disease

July 2, 2012
By Anette Breindl
Short-term, the chances of surviving a heart attack are now quite good – on the order of 90 percent. But the longer-term statistics remain grim. Within a year of a first heart attack, nearly 20 percent of victims will have a second outright heart attack, and fully half of them will have additional heart problems that stay short of a full heart attack.
Read More

In Preclinical Experiments, Gene Therapy Prevents Nicotine Kick

June 28, 2012
By Anette Breindl
Scientists from Weill Cornell Medical College have developed what they hope will turn into a novel anti-addiction strategy. In mice, they were able to prevent the effects of nicotine by treating the animals with an anti-nicotine antibody – administered via gene therapy.
Read More

For Patient Advocacy Groups, a Broader Role in Drug Discovery

June 25, 2012
By Anette Breindl
BOSTON – In the mid-20th century, a cancer patient could die without ever hearing his or her diagnosis. Many doctors, in fact, considered that the ethical thing to do. Since patients had no voice in their treatments, why saddle them with the knowledge of their diseases – which, at the time, could carry considerable social stigma?
Read More

In Microbiome, Species Diversity Meets Functional Convergence

June 25, 2012
By Anette Breindl
Human cells are a minority in their own body, outnumbered 10 to one by cells of the microbiome, commensal microorganisms. "Ninety percent of the DNA that we're carrying around is bacterial," Peter DiLaura told BioWorld Insight, with some viruses and fungi thrown in for good measure.
Read More

After Nearly a Year's Delay, Details of Airborne Bird Flu

June 22, 2012
By Anette Breindl
The American Association for the Advancement of Science published full details of a paper by Dutch researchers that demonstrates H5N1 avian influenza, a highly lethal but to date not very contagious strain of the flu, can acquire mutations that allow it to be spread via aerosol transmission.
Read More

Faster Information, Leaner Times Make Sharing Look Attractive

June 21, 2012
By Anette Breindl
BOSTON – As budgets and success rates shrink, talk tends to be of organizations becoming leaner and meaner. But at a standing-room only session on Wednesday, speakers from government and industry looked at ways to become leaner and nicer instead, in the form of so-called precompetitive collaboration.
Read More

Human Microbiome Project: 'Done a Lot,' Still Early Days

June 20, 2012
By Anette Breindl
In the biotechnology world, all eyes are on Boston and the BIO 2012 convention this week. But across the country, in San Francisco, the American Society for Microbiology is also having its annual meeting. And on Tuesday, a late-breaking session at that meeting reported the newest findings of the Human Microbiome Project.
Read More
Previous 1 2 … 241 242 243 244 245 246 247 248 249 … 403 404 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 20, 2026.
  • ALN-5288 lowers tau levels in preclinical models

    BioWorld Science
    Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
  • International currency symbols

    Capital remains selective in ‘barbell’ biotech market

    BioWorld
    Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
  • Elderly hands holding broken brain structure

    Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability

    BioWorld Science
    Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
  • Neuropathy illustrated in legs and feet

    LIT-002 is strong candidate for autism and neuropathic pain

    BioWorld Science
    Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing